Phathom Pharmaceuticals(PHAT) - 2025 Q1 - Quarterly Results

Strategic Initiatives to Drive Topline Growth, Cost Reductions and Organizational Changes: Exhibit 99.1 Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update FLORHAM PARK, N.J., May 1, 2025 — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the first quarter ended March 31, 2025, and provided a business update ...